Kazia Therapeutics Limited Share Price
NASDAQ: KZIAKazia Therapeutics Limited Stock Performance
Kazia Therapeutics Limited Share Price Today
As of 30 October 2026, Kazia Therapeutics Limited's share price is $8.70. The stock opened at $8.67, compared to its previous close of $8.30. During today's trading session, Kazia Therapeutics Limited's share price traded between $8.59 and $8.80, with an average price of $8.70. Over the past 52 weeks, the stock has recorded a high of $17.19 and a low of $4.90. In terms of performance, Kazia Therapeutics Limited's share price has declined by 36.50% over the last six months and is up 12.26% on a year-on-year basis.
Kazia Therapeutics Limited Share Price Chart
About Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Kazia Therapeutics Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $9.58 | $8.69 | -9.57% |
Sep 2026 | $13.24 | $9.61 | -21.74% |
Aug 2026 | $12.70 | $12.28 | -2.62% |
Jul 2026 | $14.50 | $12.61 | -11.26% |
Jun 2026 | $12.72 | $14.21 | +12.69% |
May 2026 | $13.12 | $12.61 | -7.96% |
Apr 2026 | $7.46 | $13.70 | +84.89% |
Mar 2026 | $7.90 | $7.41 | -12.26% |
Feb 2026 | $5.86 | $8.45 | +46.11% |
Jan 2026 | $6.75 | $5.78 | -14.50% |
Dec 2025 | $10.46 | $6.76 | -31.20% |
Nov 2025 | $7.46 | $9.82 | +26.77% |